84 related articles for article (PubMed ID: 26218130)
1. Enhanced proteotoxic stress: one of the contributors for hyperthermic potentiation of the proteasome inhibitor bortezomib using magnetic nanoparticles.
Alvarez-Berrios MP; Castillo A; Merida F; Mendez J; Rinaldi C; Torres-Lugo M
Biomater Sci; 2015 Feb; 3(2):391-400. PubMed ID: 26218130
[TBL] [Abstract][Full Text] [Related]
2. Magnetic fluid hyperthermia enhances cytotoxicity of bortezomib in sensitive and resistant cancer cell lines.
Alvarez-Berríos MP; Castillo A; Rinaldi C; Torres-Lugo M
Int J Nanomedicine; 2014; 9():145-53. PubMed ID: 24379665
[TBL] [Abstract][Full Text] [Related]
3. Enhanced reduction in cell viability by hyperthermia induced by magnetic nanoparticles.
Rodríguez-Luccioni HL; Latorre-Esteves M; Méndez-Vega J; Soto O; Rodríguez AR; Rinaldi C; Torres-Lugo M
Int J Nanomedicine; 2011; 6():373-80. PubMed ID: 21499427
[TBL] [Abstract][Full Text] [Related]
4. Hyperthermic potentiation of cisplatin by magnetic nanoparticle heaters is correlated with an increase in cell membrane fluidity.
Alvarez-Berríos MP; Castillo A; Mendéz J; Soto O; Rinaldi C; Torres-Lugo M
Int J Nanomedicine; 2013; 8():1003-13. PubMed ID: 23493492
[TBL] [Abstract][Full Text] [Related]
5. In vitro Ultrasonic Potentiation of 2-Phenylethynesulfonamide/Magnetic Fluid Hyperthermia Combination Treatments for Ovarian Cancer.
Mérida F; Rinaldi C; Juan EJ; Torres-Lugo M
Int J Nanomedicine; 2020; 15():419-432. PubMed ID: 32021188
[TBL] [Abstract][Full Text] [Related]
6. Bortezomib in Kidney Transplant: Current Use and Perspectives.
Requiao-Moura LR; de Sandes-Freitas TV; Marcelo-Gomes G; Rangel EB
Curr Drug Metab; 2017; 18(12):1136-1146. PubMed ID: 29165070
[TBL] [Abstract][Full Text] [Related]
7. Ricolinostat (ACY-1215) induced inhibition of aggresome formation accelerates carfilzomib-induced multiple myeloma cell death.
Mishima Y; Santo L; Eda H; Cirstea D; Nemani N; Yee AJ; O'Donnell E; Selig MK; Quayle SN; Arastu-Kapur S; Kirk C; Boise LH; Jones SS; Raje N
Br J Haematol; 2015 May; 169(3):423-34. PubMed ID: 25709080
[TBL] [Abstract][Full Text] [Related]
8. Proteasome inhibitor b-AP15 induces enhanced proteotoxicity by inhibiting cytoprotective aggresome formation.
Hillert EK; Brnjic S; Zhang X; Mazurkiewicz M; Saei AA; Mofers A; Selvaraju K; Zubarev R; Linder S; D'Arcy P
Cancer Lett; 2019 Apr; 448():70-83. PubMed ID: 30768956
[TBL] [Abstract][Full Text] [Related]
9. Bortezomib induces protective autophagy through AMP-activated protein kinase activation in cultured pancreatic and colorectal cancer cells.
Min H; Xu M; Chen ZR; Zhou JD; Huang M; Zheng K; Zou XP
Cancer Chemother Pharmacol; 2014 Jul; 74(1):167-76. PubMed ID: 24842158
[TBL] [Abstract][Full Text] [Related]
10. BAG3 induction is required to mitigate proteotoxicity via selective autophagy following inhibition of constitutive protein degradation pathways.
Rapino F; Jung M; Fulda S
Oncogene; 2014 Mar; 33(13):1713-24. PubMed ID: 23644654
[TBL] [Abstract][Full Text] [Related]
11. EGCG antagonizes Bortezomib cytotoxicity in prostate cancer cells by an autophagic mechanism.
Modernelli A; Naponelli V; Giovanna Troglio M; Bonacini M; Ramazzina I; Bettuzzi S; Rizzi F
Sci Rep; 2015 Oct; 5():15270. PubMed ID: 26471237
[TBL] [Abstract][Full Text] [Related]
12. Bortezomib-mediated downregulation of S-phase kinase protein-2 (SKP2) causes apoptotic cell death in chronic myelogenous leukemia cells.
Iskandarani A; Bhat AA; Siveen KS; Prabhu KS; Kuttikrishnan S; Khan MA; Krishnankutty R; Kulinski M; Nasr RR; Mohammad RM; Uddin S
J Transl Med; 2016 Mar; 14():69. PubMed ID: 26956626
[TBL] [Abstract][Full Text] [Related]
13. Proteasome inhibition potentiates the cytotoxic effects of hyperthermia in HT-29 colon cancer cells through inhibition of heat shock protein 27.
Chen F; Rezavi R; Wang CC; Harrison LE
Oncology; 2007; 73(1-2):98-103. PubMed ID: 18337621
[TBL] [Abstract][Full Text] [Related]
14. Magnetic fluid hyperthermia (MFH)reduces prostate cancer growth in the orthotopic Dunning R3327 rat model.
Johannsen M; Thiesen B; Jordan A; Taymoorian K; Gneveckow U; Waldöfner N; Scholz R; Koch M; Lein M; Jung K; Loening SA
Prostate; 2005 Aug; 64(3):283-92. PubMed ID: 15726645
[TBL] [Abstract][Full Text] [Related]
15. Bik/NBK accumulation correlates with apoptosis-induction by bortezomib (PS-341, Velcade) and other proteasome inhibitors.
Zhu H; Zhang L; Dong F; Guo W; Wu S; Teraishi F; Davis JJ; Chiao PJ; Fang B
Oncogene; 2005 Jul; 24(31):4993-9. PubMed ID: 15824729
[TBL] [Abstract][Full Text] [Related]
16. Enantioselective synthesis of adamantylalanine and carboranylalanine and their incorporation into the proteasome inhibitor bortezomib.
de Bruin G; Mock ED; Hoogendoorn S; van den Nieuwendijk AM; Mazurek J; van der Marel GA; Florea BI; Overkleeft HS
Chem Commun (Camb); 2016 Mar; 52(21):4064-7. PubMed ID: 26894389
[TBL] [Abstract][Full Text] [Related]
17. Effects of magnetic fluid hyperthermia (MFH) on C3H mammary carcinoma in vivo.
Jordan A; Scholz R; Wust P; Fähling H; Krause J; Wlodarczyk W; Sander B; Vogl T; Felix R
Int J Hyperthermia; 1997; 13(6):587-605. PubMed ID: 9421741
[TBL] [Abstract][Full Text] [Related]
18. In vitro study on apoptotic cell death by effective magnetic hyperthermia with chitosan-coated MnFe₂O₄.
Oh Y; Lee N; Kang HW; Oh J
Nanotechnology; 2016 Mar; 27(11):115101. PubMed ID: 26871973
[TBL] [Abstract][Full Text] [Related]
19. Hyperthermia induced by magnetic nanoparticles improves the effectiveness of the anticancer drug cis-diamminedichloroplatinum.
Lee JS; Rodríguez-Luccioni HL; Méndez J; Sood AK; Lpez-Berestein G; Rinaldi C; Torres-Lugo M
J Nanosci Nanotechnol; 2011 May; 11(5):4153-7. PubMed ID: 21780419
[TBL] [Abstract][Full Text] [Related]
20. A facile microwave synthetic route for ferrite nanoparticles with direct impact in magnetic particle hyperthermia.
Makridis A; Chatzitheodorou I; Topouridou K; Yavropoulou MP; Angelakeris M; Dendrinou-Samara C
Mater Sci Eng C Mater Biol Appl; 2016 Jun; 63():663-70. PubMed ID: 27040263
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
